Sulfuric Acid

Sulfuric Acid

SCHEMBL9705769

CC(=O)OC[C@H]1O[C@@](COC(C)=O)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.[Ba]

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.36
CYP2D6 P10635 1/20 0.35
THRB P10828 1/20 0.35
HSD17B10 Q99714 1/20 0.35
EPHX2 P34913 1/20 0.35
CA2 P00918 10/20 0.34
CA12 O43570 9/20 0.34
CA1 P00915 9/20 0.34
CA9 Q16790 7/20 0.34
CD69 Q07108 1/20 0.34
CA4 P22748 2/20 0.33
CA5A P35218 2/20 0.33
CA7 P43166 2/20 0.33
CA5B Q9Y2D0 2/20 0.33
CDK1 P06493 1/20 0.33
CCNB1 P14635 1/20 0.33
FGF1 P05230 1/20 0.33
FGF2 P09038 1/20 0.33
PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2888526 0.95 CYP2D6 (0.38) LDHACYP2D6THRBHSD17B10EPHX2
SCHEMBL4581260 0.89 CYP2D6 (0.41) LDHACYP2D6THRBHSD17B10EPHX2
SCHEMBL3418341 0.89 CDK1 (0.43) LDHACYP2D6THRBHSD17B10EPHX2
SCHEMBL8038328 0.85 CYP2D6 (0.47) CYP2D6THRBHSD17B10CA2CA12
SCHEMBL1614946 0.84 CDK1 (0.42) LDHAEPHX2CA2CA9CD69
SCHEMBL8939201 0.83 LDHA (0.43) LDHACYP2D6THRBHSD17B10EPHX2
Sucrose Octaacetate SCHEMBL23549924 0.82 CYP2D6 (0.53) CYP2D6THRBHSD17B10CA2CA12
Sucrose Octaacetate SCHEMBL48906 0.82 CYP2D6 (0.53) CYP2D6THRBHSD17B10CA2CA12
Sucrose Octaacetate SCHEMBL16330227 0.82 CYP2D6 (0.53) CYP2D6THRBHSD17B10CA2CA12
Sucrose Octaacetate SCHEMBL23549923 0.82 CYP2D6 (0.53) CYP2D6THRBHSD17B10CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0230023-B1 PHARMACEUTICAL COMPOSITIONS FOR THE ENHANCEMENT OF WOUND HEALING MARION MERRELL DOW INC. (US) 1992-09-02 EP disclosed
US-4912093-A Polysulfated (mono- or oligo-)saccharide MARION LABORATORIES, INC. (US) 1990-03-27 US disclosed
EP-0230023-A2 Pharmaceutical compositions for the enhancement of wound healing MARION MERRELL DOW INC. (US) 1987-07-29 EP disclosed